Search
.Management Sciences
A. The drawer of the bill
B. The person responsible for dishonour
C. The holder of the bill
D. The endorser of the bill
B. The noting charges are the charges paid to Notary Public for presenting a bill for
payment and to note the fact of dishonour. The charges are to be borne by the person responsible
for dishonour who is none other than the drawee. Thus, the correct answer is B..
The drawer of the bill A. is incorrect answer because the drawer may pay the charges initially but ultimately they are to be borne by the drawee.
The holder of the C. is entitled to receive the payment of the bill and to bear the noting charges on the bill. The endorser D. may be the drawer of the bill in which case he will recover the noting charges from the drawee of the bill. Thus B. is the correct answer.
Related Mcqs:
- Which of the following will affect the agreement of a trial balance?
- A. Complete omission of a transaction B. Partial omission of a transaction C. Error of principle D. Compensating errors...
- Which is the most important characteristic that all assets of a business have?
- A. Long life of assets B. Value of assets C. Intangible nature of assets D. Future economic benefits...
- An increase in provision for bad debt will____________?
- A. Decrease net income B. Decrease liabilities C. Increase net income D. Increase liabilities...
- Which of the following statements is true?
- A. If a Trial Balance tallies, it always means that none of the transactions has been completely omitted B. A Trial Balance will not tally if a transaction is omitted C. A customer to whom goods have been sold on credit cannot avail himself of a cash discount D. A credit balance in the Pass … Which of the following statements is true?Read More...
- Which one of the following is a capital expenditure?
- A. Compensation paid to Directors on termination of their services B. Expenditure incurred in connection with the renewal of a Trade Mark. C. Gratuities paid to Directors on termination of their services. D. Royalty paid in installments for the purchase of rights to manufacture and sell patient medicines....
Recent Comments